CCR5 and HIV-1 infection: established that ZFNs effectively disrupt CCR5 in human CD4+ T cells and that this disruption provides sustained inhibition of HIV-1 infection in vitro and in vivo using the immunodeficient NOD/Shi-scid/IL-2Rγnull (NOG) mouse model.